| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
erb-b2 receptor tyrosine kinase 3 | 0.448 | 0.808 | 1.7E-15 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
elongation factor like GTPase 1 | 0.638 | 0.577 | 5.1E-08 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
SH3 domain containing GRB2 like 1, endophilin A2 | 0.686 | 0.346 | 1.2E-02 |
|
disease | 0.400 | None | 0 | 0 | |||||||||||
|
signal recognition particle 54 | 0.612 | 0.769 | 1.00 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
T cell immune regulator 1, ATPase H+ transporting V0 subunit a3 | 0.565 | 0.692 | 2.4E-13 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
DnaJ heat shock protein family (Hsp40) member C21 | 0.606 | 0.731 | 2.1E-07 |
|
disease | 0.100 | None | 0 | 1 | |||||||||||
|
glutamate decarboxylase like 1 | 0.497 | 0.808 | 1.4E-21 |
|
disease | 0.110 | None | 0.500 | 1 | 14 | 2017 | 2019 | ||||||||
|
phosphatidylinositol glycan anchor biosynthesis class A | 0.575 | 0.654 | 0.96 |
|
disease | 0.120 | None | 0.500 | 0 | 0 | 1995 | 2001 | ||||||||
|
gelsolin | 0.475 | 0.885 | 3.9E-11 |
|
disease | 0.120 | None | 0.667 | 1 | 11 | 2011 | 2019 | ||||||||
|
neurotrophic receptor tyrosine kinase 3 | 0.522 | 0.692 | 1.00 |
|
disease | 0.430 | None | 0.800 | 1 | 4 | 1999 | 2018 | ||||||||
|
HRas proto-oncogene, GTPase | 0.378 | 0.885 | 8.0E-02 |
|
disease | 0.500 | None | 0.833 | 1 | 8 | 1987 | 2016 | ||||||||
|
ROS proto-oncogene 1, receptor tyrosine kinase | 0.439 | 0.885 | 1.6E-72 |
|
disease | 0.160 | None | 0.857 | 1 | 5 | 2010 | 2019 | ||||||||
|
serine and arginine rich splicing factor 2 | 0.561 | 0.731 | 0.48 |
|
disease | 0.200 | None | 0.900 | 0 | 0 | 2000 | 2019 | ||||||||
|
KRAS proto-oncogene, GTPase | 0.320 | 0.923 | 7.9E-04 |
|
disease | 0.700 | None | 0.939 | 9 | 7 | 1987 | 2020 | ||||||||
|
Janus kinase 2 | 0.385 | 0.885 | 0.65 |
|
disease | 0.800 | None | 0.945 | 11 | 2 | 2005 | 2019 | ||||||||
|
DNA methyltransferase 3 alpha | 0.445 | 0.846 | 7.4E-39 |
|
disease | 0.800 | limited | 0.955 | 10 | 4 | 2009 | 2019 | ||||||||
|
KIT proto-oncogene, receptor tyrosine kinase | 0.366 | 0.808 | 0.98 |
|
disease | 0.800 | moderate | 0.955 | 3 | 3 | 1989 | 2019 | ||||||||
|
MLLT10 histone lysine methyltransferase DOT1L cofactor | 0.551 | 0.462 | 1.00 |
|
disease | 0.500 | None | 0.958 | 0 | 0 | 1995 | 2019 | ||||||||
|
WT1 transcription factor | 0.422 | 0.808 | 1.00 |
|
disease | 0.700 | None | 0.959 | 6 | 1 | 1994 | 2020 | ||||||||
|
myosin heavy chain 11 | 0.528 | 0.731 | 0.77 |
|
disease | 0.500 | None | 0.960 | 1 | 7 | 1995 | 2020 | ||||||||
|
isocitrate dehydrogenase (NADP(+)) 2 | 0.434 | 0.808 | 0.88 |
|
disease | 0.700 | None | 0.961 | 14 | 5 | 2010 | 2019 | ||||||||
|
tumor protein p53 | 0.236 | 0.962 | 0.53 |
|
disease | 0.700 | None | 0.961 | 6 | 27 | 1986 | 2020 | ||||||||
|
ATP binding cassette subfamily G member 2 (Junior blood group) | 0.419 | 0.885 | 2.1E-32 |
|
disease | 0.200 | None | 0.962 | 1 | 6 | 2000 | 2017 | ||||||||
|
core-binding factor subunit beta | 0.601 | 0.538 | 0.96 |
|
disease | 0.500 | None | 0.966 | 0 | 0 | 1993 | 2020 | ||||||||
|
isocitrate dehydrogenase (NADP(+)) 1 | 0.424 | 0.808 | 2.6E-12 |
|
disease | 0.700 | None | 0.969 | 8 | 2 | 2009 | 2020 |